1. Home
  2. BYON vs CMRX Comparison

BYON vs CMRX Comparison

Compare BYON & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYON
  • CMRX
  • Stock Information
  • Founded
  • BYON 1997
  • CMRX 2000
  • Country
  • BYON United States
  • CMRX United States
  • Employees
  • BYON N/A
  • CMRX N/A
  • Industry
  • BYON Catalog/Specialty Distribution
  • CMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYON Consumer Discretionary
  • CMRX Health Care
  • Exchange
  • BYON Nasdaq
  • CMRX Nasdaq
  • Market Cap
  • BYON 377.1M
  • CMRX 394.1M
  • IPO Year
  • BYON N/A
  • CMRX 2013
  • Fundamental
  • Price
  • BYON $5.03
  • CMRX $8.47
  • Analyst Decision
  • BYON Hold
  • CMRX Hold
  • Analyst Count
  • BYON 9
  • CMRX 4
  • Target Price
  • BYON $10.93
  • CMRX $8.51
  • AVG Volume (30 Days)
  • BYON 3.1M
  • CMRX 8.8M
  • Earning Date
  • BYON 05-05-2025
  • CMRX 04-30-2025
  • Dividend Yield
  • BYON N/A
  • CMRX N/A
  • EPS Growth
  • BYON N/A
  • CMRX N/A
  • EPS
  • BYON N/A
  • CMRX N/A
  • Revenue
  • BYON $1,394,964,000.00
  • CMRX $159,000.00
  • Revenue This Year
  • BYON N/A
  • CMRX N/A
  • Revenue Next Year
  • BYON $9.91
  • CMRX $2,324.80
  • P/E Ratio
  • BYON N/A
  • CMRX N/A
  • Revenue Growth
  • BYON N/A
  • CMRX N/A
  • 52 Week Low
  • BYON $4.45
  • CMRX $0.75
  • 52 Week High
  • BYON $37.10
  • CMRX $8.48
  • Technical
  • Relative Strength Index (RSI)
  • BYON 33.92
  • CMRX 84.52
  • Support Level
  • BYON $5.07
  • CMRX $8.41
  • Resistance Level
  • BYON $6.43
  • CMRX $8.47
  • Average True Range (ATR)
  • BYON 0.61
  • CMRX 0.24
  • MACD
  • BYON -0.21
  • CMRX 0.28
  • Stochastic Oscillator
  • BYON 3.60
  • CMRX 99.75

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

About CMRX Chimerix Inc.

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Share on Social Networks: